Quantcast

Latest Organofluorides Stories

2014-03-24 20:23:39

DUBLIN, March 24, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zkjlpz/investigation) has announced the addition of the "Investigation Report on China Atorvastatin Market, 2009-2018" [http://www.researchandmarkets.com/research/zkjlpz/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The prevalence rate of abnormal blood lipid in China is lower than that in most developed...

2014-03-24 20:23:34

Five Phase 3 Studies With Evolocumab (AMG 145) to be Featured in Late-Breaking and Clinical Research Presentations - Data Form the Basis of Global Filing Plan THOUSAND OAKS, Calif., March 24, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present pivotal Phase 3 data from five clinical studies evaluating evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density...

2014-03-24 16:24:53

TOKYO, March 24, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) today announced that Astellas has obtained marketing approval of their oral androgen receptor signaling inhibitor, XTANDI(®) capsules 40mg (development code: MDV3100; generic name: enzalutamide) for the treatment of patients with castration-resistant prostate cancer in Japan. Astellas filed the application for approval in Japan in May 2013. XTANDI is a once-daily, oral androgen receptor signaling inhibitor that acts on...

2014-03-24 12:31:07

KANSAS CITY, Kan., March 24, 2014 /PRNewswire/ -- Two Kansas women who took Lipitor to reduce their cholesterol levels and later developed diabetes have filed Lipitor lawsuits against Pfizer, announced Robert K. Jenner, attorney with Janet, Jenner & Suggs, LLC. In separate filings, Alice Beems of Topeka (Case no. 2:14-cv-2088), and Nora Hammerschmidt of Plainville (Case no. 2:14-cv-2089) claim Pfizer failed to warn doctors and their patients that Lipitor, also called...

2014-03-21 23:01:52

The Firm is investigating Risperdal lawsuits on behalf of men and boys who allegedly experienced gynecomastia (male breast development) due to Risperdal. New York, NY (PRWEB) March 21, 2014 Johnson & Johnson has been successful in its bid to have a $1.2 billion verdict rendered in an Arkansas Risperdal lawsuit (http://www.risperdallawsuitcenter.com/) overturned, Bernstein Liebhard LLP reports. According to a decision rendered yesterday, the high court ruled that the state had relied...

2014-03-20 23:29:36

National network of attorneys initiates offer of no-cost consultations to consumers seeking compensation for allegations of gynecomastia, other side effects. San Diego, CA (PRWEB) March 20, 2014 http://www.resource4thepeople.com/defectivedrugs/risperdal.html Resource4thePeople announced today that its national network of attorneys is now investigating claims over allegations that the antipsychotic medication Risperdal may cause a breast-growth condition known as gynecomastia or other side...

2014-03-20 08:29:49

Independent Data Monitoring Committee Recommends Halting Trial and Unblinding Data Based on Treatment Efficacy TITUSVILLE, N.J., March 20, 2014 /PRNewswire/ -- Janssen Research & Development, LLC announced today that following an Independent Data Monitoring Committee (IDMC) recommendation based on positive efficacy, it has halted early a Phase 3 clinical study of paliperidone palmitate 3-month formulation, an investigational treatment for symptoms of schizophrenia in adults. "We are...

2014-03-20 08:28:57

BETHLEHEM, Pa., March 20, 2014 /PRNewswire/ -- Saladax Biomedical, Inc. announced today that Saladax Biomedical Laboratories is offering a simple blood test for the personalization and optimization of 5-fluorouracil (5-FU) dosing to help oncologists improve treatment outcomes and minimize the drug's toxic side effects. The test is called My5-FU(TM). 5-FU is a chemotherapy drug commonly used in the treatment of many different cancer types, including colorectal, head & neck and breast...

2014-03-18 23:33:25

Rapid CYP2C19 Testing for Personalized Antiplatelet Therapy in 600-Patient Clinical Trial with Spartan Bioscience (PRWEB) March 18, 2014 Spartan Bioscience today announced the start of a 600-patient study of personalized medicine for cardiac stent patients in Germany. The study is part of a larger clinical trial entitled “Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes Trial (TROPICAL-ACS)”. TROPICAL-ACS, led by principal...

2014-03-18 23:21:39

The improper marketing of a drug called Risperdal has led to a landmark settlement with the Federal Government that could lead the way for future settlements to injured parties. The Pennsylvania Risperdal lawyers of Handler Henning Rosenberg have announced an expanded practice area dedicated to helping young men and boys injured by this medication gain compensation. Harrisburg, PA (PRWEB) March 18, 2014 This past November, the Justice Department of the United States reached a settlement...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related